Alectinib in crizotinib-resistant, ALK-positive NSCLC

Lancet Oncol. 2016 Feb;17(2):134-135. doi: 10.1016/S1470-2045(15)00555-0. Epub 2015 Dec 19.
No abstract available

Publication types

  • Comment

MeSH terms

  • Antineoplastic Agents / therapeutic use*
  • Carbazoles / therapeutic use*
  • Carcinoma, Non-Small-Cell Lung / drug therapy*
  • Female
  • Humans
  • Lung Neoplasms / drug therapy*
  • Male
  • Piperidines / therapeutic use*

Substances

  • Antineoplastic Agents
  • Carbazoles
  • Piperidines